Delirium, Dementia & Protecting the Aging Brain | Dr. Tammy Hshieh, MD, MPH - Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife

Episode notes

Send us Fan Mail We often assume confusion after surgery is temporary. But what if those few days of delirium are actually a major turning point in the aging brain? New research from Harvard and Hebrew SeniorLife suggests postoperative delirium may be the strongest predictor of long-term cognitive decline - and what we're learning could fundamentally change how we think about dementia and healthy aging. Each year, millions of older adults undergo surgery successfully, only to experience episodes of confusion, disorientation, memory impairment, or altered awareness in the days that follow. For decades, many clinicians viewed postoperative delirium as a temporary complication that resolved once patients left the hospital. But emerging research suggests a much more profound story. Our guest today is Dr. Tammy Hshieh, MD, MPH, is physician-scientist, geriatrician, and internationally recognized expert on delirium, cognitive impairment, and healthy aging. Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Building Brain-Healthy WorkplacesTeam Building Saves The World · on Dementia60 / 100
• Ep#225 Neuroscience Proves These Leadership Habits Damage Your BrainLeadership Performance Under Pressure · on Brain Health55 / 100
• Biology Matters TrailerBiology Matters · on Dementia31 / 100
• Dementia in Down Syndrome: Is It Inevitable?University of California Audio Podcasts · on Dementia

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen